Zpráva o průběhu neintervenční observační studie Ponderosa Annual Report Sledované období: 4. červenec 2021 – 4. červenec 2022

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Title in English	Report on the progress of the non-interventional observational study Ponderosa Annual Report Observed period: July 4, 2021 - July 4, 2022
Authors	DEMLOVÁ Regina MATYŠKOVÁ Šárka
Year of publication	2022
MU Faculty or unit	Faculty of Medicine
web	https://www.uniklinikum-jena.de/kim2/H%C3%A4matologie+und+Internistische+Onkologie/Forschung/Studienzentrale/Eigeninitiierte+Studien/Ponderosa.html Ponderosa
Description	Ponderosa study Interim Report: Observational study on CML patients in any phase treated with ponatinib (Iclusig®) at any dose.This study aims at giving a picture of real-life treatment with ponatinib in CML patients. The study will assess the incidence of adverse events (AEs) and response to treatment. The annual report of the observational study contains data about recruitment of subjects in individual clinical trial centers, the incidence of serious adverse reactions and their reporting, identified protocol violations and information on newly identified findings on the investigational medicinal product in relation to its safety and efficacy.
Related projects:	Český národní uzel Evropské sítě infrastruktur klinického výzkumu (CZECRIN)